BioCardia
BCDA
13 hedge funds and large institutions have $272K invested in BioCardia in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
44% more funds holding
Funds holding: 9 → 13 (+4)
0.17% less ownership
Funds ownership: 2.9% → 2.73% (-0.17%)
14% less capital invested
Capital invested by funds: $317K → $272K (-$44.5K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$58.6K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$11.1K |
| 4 |
Morgan Stanley
New York
|
+$9.34K |
| 5 |
JP Morgan Chase
New York
|
+$2.11K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$62.7K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.75K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$77 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $95.6K | -$62.7K | -26,754 | -38% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $67.5K | +$38.1K | +16,251 | +110% |
|
|
CM
3
CM Management
Gulf Breeze,
Florida
| $54.5K | +$58.6K | +25,000 | New |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $28.1K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $10.4K | +$11.1K | +4,750 | New |
|
|
6
Morgan Stanley
New York
| $8.76K | +$9.34K | +3,986 | +13,287% |
|
|
PP
7
Pingora Partners
Wilson,
Wyoming
| $2.26K | – | – | – |
|
|
8
JP Morgan Chase
New York
| $1.96K | +$2.11K | +899 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1.17K | -$1.75K | -747 | -58% |
|
|
10
Bank of America
Charlotte,
North Carolina
| $901 | -$77 | -33 | -7% |
|
|
GRP
11
Global Retirement Partners
San Rafael,
California
| $896 | – | – | – |
|
12
Osaic Holdings
Scottsdale,
Arizona
| $132 | – | – | – |
|
|
SS
13
SBI Securities
Tokyo,
Japan
| $33 | +$35 | +15 | New |
|
BCDA Hedge Fund Activity: Q4 2024 in Review
13 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in BioCardia (BCDA) for Q4 2024, worth a combined $272K — down 14% from $317K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BCDA positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was CM Management, opening a new position worth an estimated $58.6K. The largest seller was Susquehanna International Group, cutting an estimated $62.7K.
- 13 institutional investors held BioCardia (BCDA) as of Q4 2024, up from 9 in Q3 2024.
- Funds reported $272K of BioCardia stock for Q4 2024, down 14% quarter-over-quarter.
- 4 funds opened new BioCardia positions in Q4 2024 and 0 closed out, a net change of +4 holders.
- The largest BioCardia buyer in Q4 2024 was CM Management, an estimated $58.6K added.
- The largest BioCardia seller in Q4 2024 was Susquehanna International Group, an estimated $62.7K sold.
Based on aggregated 13F filings for Q4 2024.